Brett King

Brett King

Company: Yale School of Medicine

Job title: Associate Professor of Dermatology

Bio:

Brett King is associate professor of dermatology at Yale University School of Medicine, specializing in skin diseases recalcitrant to first-line therapies. Dr King has pioneered the use of Janus kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of inflammatory skin disease, including alopecia areata, vitiligo, and atopic dermatitis, as well as other conditions. He has lectured nationally and internationally and published numerous articles on this and other topics. Dr. King received his B.A. at the University of California at Santa Cruz, his Ph.D. from Stanford University and his M.D. from Yale University School of Medicine. He completed medical internship at Massachusetts General Hospital and dermatology residency at Yale University School of Medicine.

Seminars:

Live Discussion & Question Time 2:30 pm

What are the clinical cross-learnings for JAK inhibitor application across both blood-related disorders and immune-mediated diseases? How can we refine clinical trial protocols to include clinically meaningful biomarkers with improved predictability of patient response and clinically meaningful endpoints? In what clinical indications do effective combination regimens that include JAK inhibitors play a role and how…Read more

day: Day One

Treatment for Alopecia Areata to Vitiligo: JAK Inhibitors & The Golden Age of Dermatology 1:30 pm

Describe the broad utility of JAK inhibitors across dermatological diseases, including alopecia areata, atopic dermatitis, dermatomyositis, granuloma annulare and sarcoidosis, lichen planus, morphea, psoriasis, and vitiligo Identify challenges of clinical trials in dermatological orphan diseasesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.